tradingkey.logo

Venus Concept Inc

VERO
1.140USD
-0.040-3.39%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
2.12MMarktkapitalisierung
VerlustKGV TTM

Venus Concept Inc

1.140
-0.040-3.39%

mehr Informationen über Venus Concept Inc Unternehmen

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Venus Concept Inc Informationen

BörsenkürzelVERO
Name des UnternehmensVenus Concept Inc
IPO-datumOct 12, 2017
CEODe Silva (Rajiv D)
Anzahl der mitarbeiter292
WertpapierartOrdinary Share
GeschäftsjahresendeOct 12
Addresse235 Yorkland Blvd Suite 900
StadtTORONTO
BörseNASDAQ OMX - NASDAQ BASIC
LandCanada
PostleitzahlM2J 4Y8
Telefon18778488430
Websitehttps://www.venusconcept.com/en-uk/
BörsenkürzelVERO
IPO-datumOct 12, 2017
CEODe Silva (Rajiv D)

Führungskräfte von Venus Concept Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
+1637.00%
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+1.00%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+1.00%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Mr. Domenic Della Penna, CPA
Mr. Domenic Della Penna, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Dr. Anthony J. (Tony) Natale, M.D.
Dr. Anthony J. (Tony) Natale, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
+1637.00%
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+1.00%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+1.00%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Products—Systems
7.86M
57.06%
Subscription—Systems
2.94M
21.31%
Products—Other
2.33M
16.93%
Services
647.00K
4.70%
Nach RegionUSD
Name
Umsatz
Anteil
United States
7.49M
54.36%
International
6.29M
45.64%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Products—Systems
7.86M
57.06%
Subscription—Systems
2.94M
21.31%
Products—Other
2.33M
16.93%
Services
647.00K
4.70%

Aktionärsstatistik

Aktualisiert: Wed, Dec 3
Aktualisiert: Wed, Dec 3
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
DRW Securities, LLC
1.60%
Madryn Asset Management, LP
0.55%
Andere
84.84%
Aktionäre
Aktionäre
Anteil
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
DRW Securities, LLC
1.60%
Madryn Asset Management, LP
0.55%
Andere
84.84%
Aktionärstypen
Aktionäre
Anteil
Venture Capital
7.54%
Investment Advisor
7.48%
Individual Investor
0.82%
Private Equity
0.55%
Investment Advisor/Hedge Fund
0.33%
Hedge Fund
0.10%
Research Firm
0.04%
Andere
83.14%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
34
298.27K
16.04%
+102.48K
2025Q3
33
256.25K
13.78%
+62.51K
2025Q2
48
303.44K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
--
--
Sep 30, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
DRW Securities, LLC
29.66K
1.6%
+29.66K
--
Sep 30, 2025
Madryn Asset Management, LP
10.19K
0.55%
--
--
Dec 11, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Geode Capital Management, L.L.C.
6.12K
0.33%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
7.79K
0.42%
+7.79K
--
Sep 30, 2025
The Vanguard Group, Inc.
2.03K
0.11%
--
--
Nov 30, 2025
Tower Research Capital LLC
1.94K
0.1%
-1.98K
-50.45%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
KeyAI